86 related articles for article (PubMed ID: 1725105)
21. Plasma proteinase inhibitors.
Bodmer JL; Schnebli HP
Schweiz Med Wochenschr; 1984 Oct; 114(40):1359-63. PubMed ID: 6208604
[TBL] [Abstract][Full Text] [Related]
22. Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro.
Campbell EJ; Senior RM; McDonald JA; Cox DL
J Clin Invest; 1982 Oct; 70(4):845-52. PubMed ID: 6181097
[TBL] [Abstract][Full Text] [Related]
23. Substrate hydrolysis by immune complex-activated neutrophils: effect of physical presentation of complexes and protease inhibitors.
Johnson KJ; Varani J
J Immunol; 1981 Nov; 127(5):1875-9. PubMed ID: 6170676
[TBL] [Abstract][Full Text] [Related]
24. Toxicity of phorbol myristate acetate-stimulated polymorphonuclear neutrophils against rat hepatocytes. Demonstration and mechanism.
Guigui B; Rosenbaum J; Préaux AM; Martin N; Zafrani ES; Dhumeaux D; Mavier P
Lab Invest; 1988 Dec; 59(6):831-7. PubMed ID: 2848980
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of proteases and protease inhibitors in the human ciliary epithelium and ODM-2 cells.
Ortego J; Escribano J; Coca-Prados M
Exp Eye Res; 1997 Aug; 65(2):289-99. PubMed ID: 9268597
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors.
Goetzl EJ
Immunology; 1975 Jul; 29(1):163-74. PubMed ID: 49293
[TBL] [Abstract][Full Text] [Related]
27. The trypsin-inhibitory efficiency of human alpha 2-macroglobulin in the presence of alpha 1-proteinase inhibitor: evidence for the formation of an alpha 2-macroglobulin--alpha 1-proteinase inhibitor complex.
Dejgaard S; Ortapamuk O; Ozer I
J Enzyme Inhib; 1999; 14(5):391-405. PubMed ID: 10488249
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes.
Weiss SJ; Curnutte JT; Regiani S
J Immunol; 1986 Jan; 136(2):636-41. PubMed ID: 3484496
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.
Bass DA; Parce JW; Dechatelet LR; Szejda P; Seeds MC; Thomas M
J Immunol; 1983 Apr; 130(4):1910-7. PubMed ID: 6833755
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of oxidative metabolism in murine polymorphonuclear leukocytes by unopsonized fungal cells: evidence for a mannose-specific mechanism.
Danley DL; Hilger AE
J Immunol; 1981 Aug; 127(2):551-6. PubMed ID: 7019326
[TBL] [Abstract][Full Text] [Related]
31. Effects of recombinant rat tumor necrosis factor-alpha and interferon-gamma on the respiratory burst of rat polymorphonuclear leukocytes in whole blood.
Vondrácek J
Folia Biol (Praha); 1997; 43(3):115-21. PubMed ID: 9338118
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].
Gosteva LA
Med Parazitol (Mosk); 1990; (4):29-31. PubMed ID: 1700263
[TBL] [Abstract][Full Text] [Related]
33. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
[TBL] [Abstract][Full Text] [Related]
34. Chemotactic activity of histones for human polymorphonuclear leukocytes.
Nowak D; Piasecka G; Hrabec E
Exp Pathol; 1990; 40(2):111-6. PubMed ID: 1964132
[TBL] [Abstract][Full Text] [Related]
35. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.
Carp H; Janoff A
J Clin Invest; 1980 Nov; 66(5):987-95. PubMed ID: 6253528
[TBL] [Abstract][Full Text] [Related]
36. Hydrogen peroxide formation and DNA base modification by tumor promoter-activated polymorphonuclear leukocytes.
Frenkel K; Chrzan K
Carcinogenesis; 1987 Mar; 8(3):455-60. PubMed ID: 3815740
[TBL] [Abstract][Full Text] [Related]
37. Role of purified serum components in polymorphonuclear leukocyte chemotaxis.
Czarnetzki BM; Schulz W
Int Arch Allergy Appl Immunol; 1980; 61(4):424-30. PubMed ID: 6154015
[TBL] [Abstract][Full Text] [Related]
38. Plasma effects on phagocytic activity and hydrogen peroxide production by polymorphonuclear leukocytes in neonates.
Fujiwara T; Kobayashi T; Takaya J; Taniuchi S; Kobayashi Y
Clin Immunol Immunopathol; 1997 Oct; 85(1):67-72. PubMed ID: 9325071
[TBL] [Abstract][Full Text] [Related]
39. Protective role of glutathione on alpha 1 proteinase inhibitor inactivation by the myeloperoxidase system. Hypothetic study for therapeutic strategy in the management of smokers' emphysema.
Gressier B; Lebegue S; Gosset P; Brunet C; Luyckx M; Dine T; Cazin M; Cazin JC; Wallaert B
Fundam Clin Pharmacol; 1994; 8(6):518-24. PubMed ID: 7721228
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity.
Ades EW; Hinson A; Chapuis-Cellier C; Arnaud P
Scand J Immunol; 1982 Jan; 15(1):109-13. PubMed ID: 6176014
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
